Clyra Medical Technologies
Chris Lyon serves as the Chief Revenue Officer at Clyra Medical Technologies, where the focus is on developing products for treating wound infections and promoting healing while minimizing antibiotic use. Prior experience includes leadership roles such as Vice President of North America at NATROX® Wound Care, where Chris advanced chronic wound care solutions, and Vice President of Sales at Imbed Biosciences, contributing to innovations in managing various types of wounds. Prior positions include roles in sales and marketing at Pure & Clean, Innovacyn, TEI Biosciences, I-Flow Corporation, and Marine Polymer Technologies, along with an extensive tenure at Ethicon, Inc. Education was completed at Michigan State University.
Previous companies
This person is not in any teams
This person is not in any offices
Clyra Medical Technologies
Clyra Medical Technologies, founded on our mission of “Make Lives Better”, is a healthcare company that develops and commercializes products designed to safely treat wound and skin infections and promote wound healing, while reducing the need for antibiotics. Clyra Medical Technologies products feature a potent and broad-spectrum antibacterial, antifungal & antiviral oxidation system. With no known acquired resistance capability we deliver it on demand and in a proper dose so that it is safe and effective.